How Genetic Testing Impacts Treatment Strategies for Advanced and Metastatic Breast Cancer

Kathy D. Miller, MD

Disclosures

July 28, 2022

Kathy D. Miller, MD, relates a patient experience that underscores the connection between proper patient evaluation and efficacious treatment for advanced and metastatic breast cancer.

In this case, the information gained by a relatively novel genetic test authorized the direct move to a single-agent protocol with pembrolizumab, which in turn produced a complete pathologic response in the patient.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....